Role of cerebrolysin® in cervical spondylotic myelopathy patients: a prospective randomized study

Cerebrolysin® is a mixture containing 85% free amino acids and 15% biologically active low-molecular weight peptides, that is believed to mimic the effects of endogenous neurotrophic factors to interact with the pathological process cascade of neurodegenerative diseases. No study has examined the effect of Cerebrolysin® on the cervical myelopathic patients.

from Sports Medicine via xlomafota13 on Inoreader http://ift.tt/2mqSfYx
via IFTTT